Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/10/2024 inter alia to consider and approve The Unaudited Financial Results (Standalone & Consolidation basis) of the Company for the quarter and half year ending on 30th September 2024 in accordance with Regulation 33 of the SEBI Listing Regulation.